Quinazoline compounds as kinase inhibitors
AssigneeDevelopment Center for Biotechnology
InventorsJiann-Jyh Huang, Chu-Bin Liao, Pao-Nien Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeDevelopment Center for Biotechnology
InventorsJiann-Jyh Huang, Chu-Bin Liao, Pao-Nien Chen
Estimating the term…
A compound for treating protein kinase-related disease or disorder having a structure of formula (A): wherein X is N or CH; Y is NH, O, or CH2; Z is an aryl or a heteroaryl; and R1, R2, R3, and R4 are independently H, halo, nitro, cyano, aryl, heteroaryl, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkenyl, heterocycloalkenyl, —ORa, —C(O)Ra, —C(O)NRaRb, —NRaC(O)Rb, —NRaRb, —S(O)2Ra, —S(O)2NRaRb, —NRaS(O)2Rb, —N═CRaRb, or —NRaC(O)NHRb, wherein each of Ra and Rb, independently, is H, alkyl, alkenyl, alkynyl, aryl, aryloxy, alkoxy, hydroxy, heteroaryl, cycloalkyl, heterocycloalkyl, cycloalkenyl, or heterocycloalkenyl, or Ra and Rb, together with the nitrogen atom to which they are bonded, form heteroaryl, heterocycloalkyl, or heterocycloalkenyl; or R3 and R4 are as defined above, and R1 and R2 together with the carbons, to which they are attached, form a heterocycloalkenyl or heteroaryl.
A compound having a structure represented by formula (II)
A compound having a structure represented by formula (II)
A compound of Formula (A),
Dependencies are inferred from the claim text.